| Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 (NCT02156544) | Chong Kun Dang Pharmaceutical | 2014-06-01 |
| Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT02202395) | Shanghai Pharmaceuticals Holding Co., Ltd | 2014-06-01 |
| Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis (NCT02187094) | Targacept Inc. | 2014-06-01 |
| Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy (NCT02028403) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-06-01 |
| Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371 (NCT02540460) | LigaChem Biosciences, Inc. | 2014-06-01 |
| Pharmacokinetics and Safety Study of PT010 in Healthy Subjects (NCT02189304) | Pearl Therapeutics, Inc. | 2014-06-01 |
| The Study of the Nonunion of Long Tubular Bone (NCT02338258) | Beijing Jishuitan Hospital | 2014-06-01 |
| Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma (NCT02128282) | Senhwa Biosciences, Inc. | 2014-06-01 |
| Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics (NCT02037074) | FORUM Pharmaceuticals Inc | 2014-06-01 |
| HAL-MPE1 First-in-human (NCT02163018) | HAL Allergy | 2014-06-01 |
| Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer (NCT02018523) | Jun Zhang | 2014-06-01 |
| AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects (NCT02163161) | Pfizer | 2014-06-01 |
| Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma (NCT02100657) | PharmaMar | 2014-06-01 |
| A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults (NCT01981486) | Pfizer | 2014-06-01 |
| Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis (NCT02670655) | Dong-A University | 2014-06-01 |
| Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1 (NCT02171819) | Institute of Vaccines and Medical Biologicals, Vietnam | 2014-06-01 |
| Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA (NCT02160574) | Zurex Pharma, Inc. | 2014-06-01 |
| Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme (NCT02285959) | Global Neurosciences Institute | 2014-06-01 |
| A Study of DCC-2701 in Participants With Advanced Solid Tumors (NCT02228811) | Deciphera Pharmaceuticals, LLC | 2014-06-01 |
| Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy (NCT02169388) | Shandong University | 2014-06-01 |
| Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section (NCT02350179) | Ain Shams University | 2014-06-01 |
| A Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals (NCT02176889) | KGK Science Inc. | 2014-06-01 |
| A Bioequivalence Study of Sanchi-Tongshu Capsule (Enteric Coated Pellets) (NCT02316730) | Pharmaceutical Factory of Chengdu HuaSun Group Inc., Ltd. | 2014-06-01 |
| Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) (NCT02054793) | Emmanuel Antonarakis, MD | 2014-06-01 |
| A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes (NCT02806960) | Eli Lilly and Company | 2014-06-01 |
| Safety and Efficacy of BMMNC in Multiple Sclerosis (MS) (NCT01883661) | Chaitanya Hospital, Pune | 2014-06-01 |
| Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects (NCT02206854) | Gerd Geisslinger | 2014-06-01 |
| Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine (NCT02154334) | Janssen Research & Development, LLC | 2014-06-01 |
| Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis (NCT02133664) | Oregon Health and Science University | 2014-06-01 |
| A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris (NCT02164084) | Novan, Inc. | 2014-06-01 |
| A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours (NCT02134340) | Centre for Probe Development and Commercialization | 2014-06-01 |
| Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS） (NCT02569463) | Peking University People's Hospital | 2014-06-01 |
| Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT02181699) | Kyowa Kirin, Inc. | 2014-06-01 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670 (NCT02202408) | SK Chemicals Co., Ltd. | 2014-06-01 |
| Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI). (NCT02350400) | Singapore General Hospital | 2014-06-01 |
| MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers (NCT02570581) | Centre Hospitalier Universitaire de Nice | 2014-06-01 |
| Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition (NCT02185846) | Pharmaceutical Research Unit, Jordan | 2014-06-01 |
| Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants (NCT02160756) | Aragon Pharmaceuticals, Inc. | 2014-06-01 |
| An Open-Label Food Effect Study of Telotristat Etiprate (NCT02157584) | Lexicon Pharmaceuticals | 2014-06-01 |
| Biomarkers of Fast Acting Therapies in Major Depression (NCT02165449) | University of California, Los Angeles | 2014-06-01 |
| Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe (NCT02127320) | Hanmi Pharmaceutical Company Limited | 2014-06-01 |
| A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male Volunteers (NCT02179866) | Hoffmann-La Roche | 2014-06-01 |
| SP2086 Pharmacokinetic Study in Renal Insufficiency Patients (NCT02815774) | Jiangsu HengRui Medicine Co., Ltd. | 2014-06-01 |
| Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus (NCT02162485) | Orion Corporation, Orion Pharma | 2014-06-01 |
| A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device (NCT02141191) | University of Pittsburgh | 2014-06-01 |
| Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas (NCT02115074) | Centre Oscar Lambret | 2014-06-01 |
| Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin (NCT02157649) | Nexgen Pharma, Inc | 2014-06-01 |
| Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation (NCT02252146) | Idera Pharmaceuticals, Inc. | 2014-06-01 |
| Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease (NCT02221947) | Neurotrope Bioscience, Inc. | 2014-06-01 |
| Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers (NCT03026855) | TotipotentRX Cell Therapy Pvt. Ltd. | 2014-06-01 |
| Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis (NCT02277574) | MedImmune LLC | 2014-06-01 |
| Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets (NCT02980757) | Disphar International B.V. | 2014-06-01 |
| MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer (NCT02041481) | City of Hope Medical Center | 2014-06-01 |
| Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity (NCT01810848) | OhioHealth | 2014-06-01 |
| Metformin to Augment Low Milk Supply (MALMS) Study (NCT02179788) | Children's Hospital Medical Center, Cincinnati | 2014-06-01 |
| Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123. (NCT02106338) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-06-01 |
| Trigeminal Nerve Stimulation (TNS) in the Treatment of Fibromyalgia (NCT02120690) | Santa Casa Medical School | 2014-06-01 |
| Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects (NCT03220633) | Antibe Therapeutics Inc. | 2014-06-01 |
| Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy (NCT02149459) | Sheba Medical Center | 2014-06-01 |
| A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain (NCT02184156) | Ampio Pharmaceuticals. Inc. | 2014-06-01 |
| Active Prevention of MSDs (Musculoskeletal Disorders, Upper and Spine Members) in the Context of Computer Screen Work (NCT02350244) | University Hospital, Clermont-Ferrand | 2014-06-01 |
| Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal (NCT02146391) | Repros Therapeutics Inc. | 2014-06-01 |
| Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma (NCT02315157) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-06-01 |
| A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers (NCT02165293) | Hoffmann-La Roche | 2014-06-01 |
| Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes (NCT02619097) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2014-06-01 |
| Hepatocyte Transplantation in Liver Failure (NCT00805610) | Virginia Commonwealth University | 2014-06-01 |
| A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements (NCT02152384) | Eli Lilly and Company | 2014-06-01 |
| A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses (NCT02215707) | Sanaria Inc. | 2014-06-01 |
| A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants (NCT02180269) | Janssen Pharmaceutical K.K. | 2014-06-01 |
| Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition (NCT02185833) | Pharmaceutical Research Unit, Jordan | 2014-06-01 |
| A Single Dose Study of Debio 1450 in Healthy Subjects (NCT02162199) | Debiopharm International SA | 2014-06-01 |
| A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS (NCT02336984) | H. Lee Moffitt Cancer Center and Research Institute | 2014-06-01 |
| Reconstruction of Jaw Bone Using Mesenchymal Stem Cells (NCT02751125) | University of Bergen | 2014-06-01 |
| Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus (NCT02206568) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-06-01 |
| Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients (NCT02166177) | Guy's and St Thomas' NHS Foundation Trust | 2014-06-01 |
| Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing (NCT02746848) | Royan Institute | 2014-06-01 |
| The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects (NCT02176668) | Yuhan Corporation | 2014-06-01 |
| A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers (NCT02171208) | Biogen | 2014-06-01 |
| Study of KCC Peptide Application in the Colon (NCT02156557) | Danielle Kim Turgeon | 2014-06-01 |
| Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2 (NCT02249728) | Prana Biotechnology Limited | 2014-06-01 |
| Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer (NCT02066532) | Dawn L. Hershman | 2014-06-01 |
| Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) (NCT01562301) | M.D. Anderson Cancer Center | 2014-06-01 |
| CART-meso in Mesothelin Expressing Cancers (NCT02159716) | University of Pennsylvania | 2014-06-01 |
| Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (NCT02204241) | European Myeloma Network B.V. | 2014-06-01 |
| Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis (NCT02144272) | Eli Lilly and Company | 2014-06-01 |
| Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers (NCT02168595) | GlycoMimetics Incorporated | 2014-06-01 |
| A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors (NCT02129205) | Pfizer | 2014-06-01 |
| Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery (NCT01816035) | University of Washington | 2014-06-01 |
| Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers (NCT02166242) | Hunan Province Tumor Hospital | 2014-06-01 |
| A Study of LY2951742 in Healthy Japanese and Caucasian Participants (NCT02104765) | Eli Lilly and Company | 2014-06-01 |
| Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074 (NCT02228733) | KBP Biosciences | 2014-06-01 |
| Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients (NCT02028117) | Akamis Bio | 2014-06-01 |
| Realizing Effectiveness Across Continents With Hydroxyurea (REACH) (NCT01966731) | Children's Hospital Medical Center, Cincinnati | 2014-06-01 |
| Vitamin-D Supplementation: Impact on Severe Pneumonia Among Under-five Children (NCT02185196) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2014-06-01 |
| Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration (NCT02163421) | Takeda | 2014-06-01 |
| Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma (NCT01900496) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-06-01 |
| Regorafenib + Panitumumab for Colorectal Cancers (NCT02199223) | University of Utah | 2014-06-01 |
| Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy (NCT01801709) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-06-01 |
| Study of Drug Combination on Pharmacokinetics in Healthy Volunteers (NCT02175602) | Bristol-Myers Squibb | 2014-06-01 |
| Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) (NCT02044601) | M.D. Anderson Cancer Center | 2014-06-01 |